Nalls Sherbakoff Group, LLC Repligen Corp Transaction History
Nalls Sherbakoff Group, LLC
- $112 Billion
- Q4 2023
A detailed history of Nalls Sherbakoff Group, LLC transactions in Repligen Corp stock. As of the latest transaction made, Nalls Sherbakoff Group, LLC holds 16 shares of RGEN stock, worth $2,504. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16
Previous 16
-0.0%
Holding current value
$2,504
Previous $2.55 Million
13.05%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding RGEN
# of Institutions
482Shares Held
56.3MCall Options Held
251KPut Options Held
458K-
Black Rock Inc. New York, NY7.57MShares$1.18 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD7.14MShares$1.12 Billion0.12% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.1MShares$799 Million0.01% of portfolio
-
State Street Corp Boston, MA1.69MShares$265 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.54MShares$242 Million1.48% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $8.69B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....